Multiple sclerosis (MS) is the most common neurological disorder among young adults. It is an auto-immune disease in which the body attacks its own tissues. The immune attack in MS targets the central nervous system. The lesions are well-localised and are called “plaques”.
Fill in your inscription today and join the Charcot Team during the 20km off Brussels on May 19, 2019. It will be a perfect day and you will be helping the MS-Research.
13 500 patients are counting on this research and thank you.
The two major research pathways that could change the future of people with multiple sclerosis, confirm themselves and a life where MS becomes a treatable and controllable condition comes a step closer.
Twice a year, the Charcot Foundation publishes a Bulletin which wants to be the objective reflection of research and last acquisitions in Multiple sclerosis as well in the field of our knowledge of the disease as of the new treatments under study
